Clinical trial
Serum Endocan Levels in Polycystic Ovary Syndrome: a Possible Marker of Angiogenic Dysfunction
NCT03019679 is registered in ClinicalTrials.gov with Tokat Gaziosmanpasa University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Endocan Levels in Polycystic Ovary Syndrome: a Possible Marker of Angiogenic Dysfunction
- Lead sponsor
- Tokat Gaziosmanpasa University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- April 30, 2017
- Enrollment
- 175 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.